Diverse functions of BRCA1 in the DNA damage response

Expert Reviews in Molecular Medicine

Volumn 3, Issue 15, 2001, Pages 1-11

  Lee, Jong Soo ^a   Chung, Jay H ^b  

^a Hanyang University   (South Korea)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012506095     PISSN: 14623994     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/S1462399401003131     Document Type: Article

References (80)

1. Easton, D.F. et al. (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52, 678–701, PubMed ID: 93212726
2. Feunteun, J. and Lenoir, G.M. (1996) BRCA1, a gene involved in inherited predisposition to breast and ovarian cancer. Biochim Biophys Acta 1242, 177–180, PubMed ID: 96183208
3. Smith, S.A. et al. (1992) Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 2, 128–131, PubMed ID: 93265136
4. Miki, Y. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71, PubMed ID: 95025896
5. Wu, L.C. et al. (1996) Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14, 430–440, PubMed ID: 97099454
6. Somasundaram, K. et al. (1997) Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389, 187–190, PubMed ID: 97441059
7. Monteiro, A.N., August, A. and Hanafusa, H. (1996) Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci U S A 93, 13595–13599, PubMed ID: 97098439
8. Ouchi, T. et al. (1998) BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A 95, 2302–2306, PubMed ID: 98151507
9. Chapman, M.S. and Verma, I.M. (1996) Transcriptional activation by BRCA1. Nature 382, 678–679, PubMed ID: 96345662
10. Bork, P. et al. (1997) A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. Faseb J 11, 68–76, PubMed ID: 97186552
11. Thomas, J.E. et al. (1996) Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 271, 28630–28635, PubMed ID: 97067093
12. Chen, Y. et al. (1996) BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56, 3168–3172, PubMed ID: 96320450
13. Lane, T.F. et al. (1995) Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9, 2712–2722, PubMed ID: 96067162
14. Marquis, S.T. et al. (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11, 17–26, PubMed ID: 96021028
15. Gudas, J.M. et al. (1995) Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55, 4561–4565, PubMed ID: 96006200
16. Gudas, J.M. et al. (1996) Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ 7, 717–723, PubMed ID: 96374658
17. Vaughn, J.P. et al. (1996) BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7, 711–715, PubMed ID: 96374657
18. Liu, C.Y. et al. (1996) Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10, 1835–1843, PubMed ID: 96312456
19. Hakem, R. et al. (1996) The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009–1023, PubMed ID: 96270504
20. Gowen, L.C. et al. (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 12, 191–194, PubMed ID: 96154193
21. Hakem, R. et al. (1997) Partial rescue of Brca1 (5–6) early embryonic lethality by p53 or p21 null mutation. Nat Genet 16, 298–302, PubMed ID: 97351516
22. Xu, X. et al. (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22, 37–43, PubMed ID: 99251577
23. Xu, X. et al. (1999) Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 3, 389–395, PubMed ID: 99214854
24. Hsu, L.C. and White, R.L. (1998) BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 95, 12983–12988, PubMed ID: 99007253
25. Larson, J.S., Tonkinson, J.L. and Lai, M.T. (1997) A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Cancer Res 57, 3351–3355, PubMed ID: 97413608
26. Shen, S.X. et al. (1998) A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17, 3115–3124, PubMed ID: 99087332
27. Abbott, D.W. et al. (1999) BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem 274, 18808–18812, PubMed ID: 99303655
28. Gowen, L.C. et al. (1998) BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009–1012, PubMed ID: 98369178
29. Moynahan, M.E. et al. (1999) Brca1 controls homology-directed DNA repair. Mol Cell 4, 511–518, PubMed ID: 20017049
30. Chen, J. et al. (1998) Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol Cell 2, 317–328, PubMed ID: 98448096
31. Scully, R. et al. (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265–275, PubMed ID: 97160847
32. Zhong, Q. et al. (1999) Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285, 747–750, PubMed ID: 99357870
33. Arnold, M.A. and Goggins, M. (2001) BRCA2 and predisposition to pancreatic and other cancers. Exp Rev Mol Med 18 May, http://www-ermm.cbcu.cam.ac.uk/0100309Xh.htm
34. Wang, Y. et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14, 927–939, PubMed ID: 20245492
35. Scully, R. et al. (1997) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425–435, PubMed ID: 97410308
36. Thomas, J.E. et al. (1997) Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage. Cell Growth Differ 8, 801–809, PubMed ID: 97362410
37. Cortez, D. et al. (1999) Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286, 1162–1166, PubMed ID: 20018333
38. Tibbetts, R.S. et al. (2000) Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 14, 2989–3002, PubMed ID: 20566643
39. Lee, J.S. et al. (2000) hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201–204, PubMed ID: 20186770
40. Ruffner, H. and Verma, I.M. (1997) BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A 94, 7138–7143, PubMed ID: 97352764
41. Ruffner, H. et al. (1999) BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol 19, 4843–4854, PubMed ID: 99303777
42. Savitsky, K. et al. (1995) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4, 2025–2032, PubMed ID: 96154672
43. Paterson, M.C. and Smith, P.J. (1979) Ataxia telangiectasia: an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet 13, 291–318, PubMed ID: 80152105
44. Lavin, M.F. and Khanna, K.K. (1999) ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int J Radiat Biol 75, 1201–1214, PubMed ID: 20015789
45. Rotman, G. and Shiloh, Y. (1999) ATM: a mediator of multiple responses to genotoxic stress. Oncogene 18, 6135–6144, PubMed ID: 20027404
46. Zhou, B.B. et al. (2000) Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem 275, 10342–10348, PubMed ID: 20209409
47. Matsuoka, S., Huang, M. and Elledge, S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893–1897, PubMed ID: 99055399
48. Chaturvedi, P. et al. (1999) Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene 18, 4047–4054, PubMed ID: 99361938
49. Blasina, A. et al. (1999) A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase. Curr Biol 9, 1–10, PubMed ID: 99108191
50. Brown, E.J. and Baltimore, D. (2000) ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 14, 397–402, PubMed ID: 20156353
51. Melchionna, R. et al. (2000) Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat Cell Biol 2, 762–765, PubMed ID: 20482185
52. Matsuoka, S. et al. (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U S A 97, 10389–10394, PubMed ID: 20442385
53. Bell, D.W. et al. (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 286, 2528–2531, PubMed ID: 20085462
54. Chehab, N.H. et al. (2000) Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 14, 278–288, PubMed ID: 20139417
55. Shieh, S.Y. et al. (2000) The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 14, 289–300, PubMed ID: 20139418
56. Hirao, A. et al. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824–1827, PubMed ID: 20175758
57. Li, S. et al. (1999) Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem 274, 11334–11338, PubMed ID: 99214217
58. Yu, X. et al. (1998) The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J Biol Chem 273, 25388–25392, PubMed ID: 98411344
59. Yarden, R.I. and Brody, L.C. (1999) BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci U S A 96, 4983–4988, PubMed ID: 99238469
60. Wang, Q. et al. (1998) BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17, 1939–1948, PubMed ID: 99002486
61. Zhang, H. et al. (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713–1721, PubMed ID: 98241175
62. Chai, Y.L. et al. (1999) The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/ CIP1 promoter. Oncogene 18, 263–268, PubMed ID: 99124132
63. Aprelikova, O.N. et al. (1999) BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci U S A 96, 11866–11871, PubMed ID: 99449774
64. Pao, G.M. et al. (2000) CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc Natl Acad Sci U S A 97, 1020–1025, PubMed ID: 20122564
65. Anderson, S.F. et al. (1998) BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet 19, 254–256, PubMed ID: 98324774
66. Harkin, D.P. et al. (1999) Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97, 575–586, PubMed ID: 99294307
67. Fan, S. et al. (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284, 1354–1356, PubMed ID: 99269272
68. Maor, S.B. et al. (2000) BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. Mol Genet Metab 69, 130–136, PubMed ID: 20188032
69. Li, S. et al. (2000) Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406, 210–215, PubMed ID: 20365735
70. Yu, X. and Baer, R. (2000) Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor. J Biol Chem 275, 18541–18549, PubMed ID: 20309814
71. Bochar, D.A. et al. (2000) BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257–265, PubMed ID: 20397761
72. Jensen, D.E. et al. (1998) BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097–1112, PubMed ID: 98187701
73. Lorick, K.L. et al. (1999) RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Natl Acad Sci U S A 96, 11364–11369, PubMed ID: 99432238
74. Jordan, V.C. and Morrow, M. (1999) Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 20, 253–278, PubMed ID: 99297160
75. Thompson, M.E. et al. (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9, 444–450, PubMed ID: 95315998
76. Wilson, C.A. et al. (1999) Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21, 236–240, PubMed ID: 99140780
77. Bianco, T. et al. (2000) Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21, 147–151, PubMed ID: 20125787
78. Dobrovic, A. and Simpfendorfer, D. (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57, 3347–3350, PubMed ID: 97413607
79. Waha, A. et al. (1998) Expression of the ATM gene is significantly reduced in sporadic breast carcinomas. Int J Cancer 78, 306–309, PubMed ID: 98437953
80. Rio, P.G. et al. (1998) Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma. Int J Oncol 13, 849–853, PubMed ID: 98408025